MANIFOLD
Will any medication be approved for Long Covid/PASC in any Western country before 2026?
19
Ṁ2.9kṀ5.8k
resolved Jan 7
Resolved
NO
Any treatment
Resolved
NO
AER002
Resolved
NO
Ampligen
Resolved
NO
Paxlovid
Resolved
NO
Temelimab
Resolved
NO
Baricitinib
Resolved
NO
Metformin
Resolved
NO
Triple anticoagulants
Resolved
NO
Any antiviral mAb
Resolved
NO
Naltrexone
Resolved
NO
Piracetam
Resolved
NO
Maraviroc
Resolved
NO
Aripiprazole
Resolved
NO
Mitodicure MDC002
Resolved
NO
Rapamycin
Resolved
NO
Prednisolone
Resolved
NO
Pyridostigmine
Resolved
NO
Etanercept
Resolved
NO
Emtricitabine + tenofovir disoproxil (Truvada)
Resolved
NO
Cyclophosphamide

Will resolve as Yes if any medication receives full approval or emergency approval or in any way receives an indication for' a significant portion of Long Covid and/or ME/CFS patients, in any of the following countries:

- USA

- UK

- Canada

- Australia

- New Zealand

- Any country in the European Free Trade Association (EU + Norway, Switzerland, Iceland, Liechtenstein)

Market context
Get
Ṁ1,000
to start trading!

🏅 Top traders

#TraderTotal profit
1Ṁ1,195
2Ṁ285
3Ṁ112
4Ṁ41
5Ṁ31
Sort by:
bought Ṁ30 NO

@Siebe can this be resolved now?

@SurvivalBias yes sorry

bought Ṁ5 NO

“or in any way becomes legally available to a significant portion” if this is your definition. Then Naltrexone should resolve to yes.

Hmm yes, that's not the intention of this question, because it's off-label and already available. (Technically, other medications like triple anticoagulants can also be prescribed off-label)

I will change it to: 'or in any way receives an indication for' a significant portion of Long Covid and/or ME/CFS patients.

Would mayo clinic proceedings having it in the list of ME/CFS meds count. Or for the US, only FDA approval counts?

Only FDA approval

© Manifold Markets, Inc.TermsPrivacy